In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Barrx grosses $6mm with Series A financing

Executive Summary

Medical device company Barrx has grossed $6mm with a Series A private financing to new investors Charter Ventures, Delphi Ventures and Alloy Ventures. Also participating were seed-round backers Stellartech Research (the company's incubator from which it was just spun out), Robert Ganz, MD, chief of gastroenterology at Abbott-Northwestern Hospital, and Brian D. Zelickson, MD, associate professor of dermatology at the University of Minnesota.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Radiofrequency Devices
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies